Related Experiment Video
Updated: May 1, 2026
Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis
Ping Li1, Juan Li1, Tengfei Chen1
1Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Abstract:
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Seeking informative diagnostic markers with greater clinical significance is essential for the early diagnosis of IPF. microRNAs (miRNAs or miRs) have emerged as novel serum diagnostic biomarkers for various diseases. In this study, we performed microarray analysis of the miRNA expression profile in the serum of patients with IPF compared to that of control subjects. We then performed a preliminary analysis of biological functions for the most differentially expressed miRNAs. Some of the microarray results were validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The results from this study provide evidence to link the biological role of miRNAs to IPF, and suggest that miRNAs may undertake a variety of functions. Additionally, we found that the altered expression levels of miR-21, miR-155 and miR-101-3p were associated with forced vital capacity (FVC) and radiological features in IPF. Our data may serve as a basis for further investigation, preferably in large prospective studies, before miRNA can be used as a non-invasive screening tool for IPF in routine clinical practice.
Insights
Idiopathic pulmonary fibrosis (IPF) diagnosis may be improved using serum microRNAs (miRNAs). Altered levels of specific miRNAs correlate with disease severity, suggesting their potential as non-invasive biomarkers for IPF.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Biomarker Discovery
Background:
- Idiopathic pulmonary fibrosis (IPF) presents significant morbidity and mortality, necessitating improved diagnostic methods.
- Early diagnosis of IPF is crucial for patient management and treatment.
- Serum microRNAs (miRNAs) are emerging as promising diagnostic biomarkers for various diseases.
Purpose of the Study:
- To investigate serum miRNA expression profiles in IPF patients compared to healthy controls.
- To identify differentially expressed miRNAs and analyze their potential biological functions in IPF.
- To explore the association of specific miRNAs with clinical parameters of IPF.
Main Methods:
- Microarray analysis of serum miRNA expression in IPF patients and controls.
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for validation.
- Preliminary functional analysis of differentially expressed miRNAs.
Main Results:
- Significant differences in serum miRNA expression profiles were observed between IPF patients and controls.
- Specific miRNAs, including miR-21, miR-155, and miR-101-3p, showed altered expression levels in IPF.
- The expression levels of these miRNAs were associated with forced vital capacity (FVC) and radiological features in IPF.
Conclusions:
- Serum miRNAs show altered expression in IPF and may be linked to disease pathogenesis.
- Specific miRNAs (miR-21, miR-155, miR-101-3p) are potential non-invasive biomarkers for IPF.
- Further large-scale prospective studies are warranted to validate miRNAs as screening tools for IPF.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs